|
Volumn 62, Issue 14, 2002, Pages 3956-3961
|
Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORINE DERIVATIVE;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
PHOTOSENSITIZING AGENT;
PORPHYRIN;
PROSTAGLANDIN E2;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CARCINOMA CELL;
CLINICAL FEATURE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG SELECTIVITY;
ENZYME INHIBITION;
FIBROSARCOMA;
MOUSE;
NONHUMAN;
PHOTODYNAMIC THERAPY;
PHOTOSENSITIZATION;
PRIORITY JOURNAL;
PROSTAGLANDIN SYNTHESIS;
PROTEIN EXPRESSION;
RADIATION EXPOSURE;
SARCOMA;
SKIN TOXICITY;
SOLID TUMOR;
TRANSCRIPTION REGULATION;
ANIMALS;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
ENZYME INDUCTION;
FEMALE;
FIBROSARCOMA;
ISOENZYMES;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MEMBRANE PROTEINS;
MICE;
MICE, INBRED C3H;
NITROBENZENES;
PHOTOCHEMOTHERAPY;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
SULFONAMIDES;
TUMOR CELLS, CULTURED;
|
EID: 0037099519
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (140)
|
References (28)
|